title: The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3.
abstract: Mucins provide a protective barrier for epithelial surfaces, and their overexpression in tumors has been implicated in malignancy. We have previously demonstrated that Muc4, a transmembrane mucin that promotes tumor growth and metastasis, physically interacts with the ErbB2 receptor tyrosine kinase and augments receptor tyrosine phosphorylation in response to the neuregulin-1beta (NRG1beta) growth factor. In the present study we demonstrate that Muc4 expression in A375 human melanoma cells, as well as MCF7 and T47D human breast cancer cells, enhances NRG1beta signaling through the phosphatidylinositol 3-kinase pathway. In examining the mechanism underlying Muc4-potentiated ErbB2 signaling, we found that Muc4 expression markedly augments NRG1beta binding to A375 cells without altering the total quantity of receptors expressed by the cells. Cell-surface protein biotinylation experiments and immunofluorescence studies suggest that Muc4 induces the relocalization of the ErbB2 and ErbB3 receptors from intracellular compartments to the plasma membrane. Moreover, Muc4 interferes with the accumulation of surface receptors within internal compartments following NRG1beta treatment by suppressing the efficiency of receptor internalization. These observations suggest that transmembrane mucins can modulate receptor tyrosine kinase signaling by influencing receptor localization and trafficking and contribute to our understanding of the mechanisms by which mucins contribute to tumor growth and progression.
authors.affiliation: University of California-Davis Cancer Center, Sacramento, California 95817, USA.
authors.forename: Melanie
authors.initials: M
authors.lastname: Funes
authors.forename: Jamie K
authors.initials: JK
authors.lastname: Miller
authors.forename: Cary
authors.initials: C
authors.lastname: Lai
authors.forename: Kermit L
authors.initials: KL
authors.lastname: Carraway
authors.forename: Colleen
authors.initials: C
authors.lastname: Sweeney
mesh_terms: D019921:Biotinylation; D002460:Cell Line; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism*; D066246:ErbB Receptors / Q000096:biosynthesis*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D055264:Mucin-4; D009077:Mucins / Q000378:metabolism / Q000502:physiology*; D020890:Neuregulin-1 / Q000378:metabolism / Q000502:physiology*; D010766:Phosphorylation; D020893:Receptor, ErbB-3 / Q000096:biosynthesis*; D066247:Receptor, ErbB-4; D015398:Signal Transduction; D014162:Transfection
chemical_list: C524658:MUC4 protein, human; D055264:Mucin-4; D009077:Mucins; D020890:Neuregulin-1; C587689:ERBB4 protein, human; D066246:ErbB Receptors; D020893:Receptor, ErbB-3; D066247:Receptor, ErbB-4